Cargando...

Prognostication with circulating tumor DNA: is it ready for prime time?

Emerging methods to detect tumor-derived DNA in the blood plasma of patients with lymphomas—so-called “circulating tumor DNA” (ctDNA)—have the potential to change the way in which lymphoma is diagnosed and managed in the clinic. The possible applications for ctDNA are numerous, including mutation ge...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Hematology Am Soc Hematol Educ Program
Autor Principal: Kurtz, David M.
Formato: Artigo
Idioma:Inglês
Publicado: American Society of Hematology 2019
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6913479/
https://ncbi.nlm.nih.gov/pubmed/31808836
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/hematology.2019000013
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!